PR Newswire | Jun 15, 2021 08:31AM EDT

Conference

06/15 07:30 CDT

BioMarin to Participate in the Virtual BofA Securities 2021 Napa Biopharma Conference SAN RAFAEL, Calif., June 15, 2021

SAN RAFAEL, Calif., June 15, 2021 /PRNewswire/ -- BioMarin Pharmaceutical Inc. (NASDAQ: BMRN) today announced that management will participate in the BofA Securities 2021 Napa Biopharma Conference on June 16, 2021 at 3:30pm ET. An audio webcast of the presentation will be available live. You can access the webcast at: https://investors.biomarin.com/. An archived version of the remarks will also be available through the Company's website for a limited time following the conference.

About BioMarin

BioMarin is a global biotechnology company that develops and commercializes innovative therapies for people with serious and life-threatening rare disorders. The company's portfolio consists of six commercialized products and multiple clinical and pre-clinical product candidates.

For additional information, please visit www.biomarin.com. Information on BioMarin's website is not incorporated by reference into this press release.

Contacts:

Investors Media

Traci McCarty Debra Charlesworth

BioMarinBioMarin Pharmaceutical Inc. Pharmaceutical Inc.

(415) 455-7558 (415) 455-7451

View original content to download multimedia: http://www.prnewswire.com/news-releases/biomarin-to-participate-in-the-virtual-bofa-securities-2021-napa-biopharma-conference-301312288.html

SOURCE BioMarin Pharmaceutical Inc.